MHK
50
-3
WMB
42
-5
FOXA
62
-2
FLR
55
-4
ADBE
43
2
AVGO
42
2
PM
49
4
AMG
71
-4
FMC
34
-10
BDX
41
-13
CMG
48
-2
REGN
40
2
BBY
46
-2
DAL
70
-2
SCHW
64
2
GOOG
75
6
TMO
40
-2
SWK
39
2
HUM
42
2
BF.B
46
-4
MHK
50
-3
WMB
42
-5
FOXA
62
-2
FLR
55
-4
ADBE
43
2
AVGO
42
2
PM
49
4
AMG
71
-4
FMC
34
-10
BDX
41
-13
CMG
48
-2
REGN
40
2
BBY
46
-2
DAL
70
-2
SCHW
64
2
GOOG
75
6
TMO
40
-2
SWK
39
2
HUM
42
2
BF.B
46
-4
Financhill
Back

Dorman Products Vs. Blueprint Medicines Industry Stock Comparison

Sell
47

DORM
Dorman Products

Last Price:
$122.14
Seasonality Move:
5.27%
Buy
53

BPMC
Blueprint Medicines

Last Price:
$129.46
Seasonality Move:
1.87%
Sell
47
Dorman Products (DORM) is a Sell

Is Dorman Products a Buy, Sell or Hold?

  • The current Dorman Products [DORM] share price is $121.45. The Score for DORM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • DORM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DORM Stock Price Chart

What is Dorman Products's stock price today?

  • The Dorman Products share price today is $121.45
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DORM is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $129.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

DORM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 43.75 Sell
Chaikin Money Flow: -85063 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (121.62 - 125.58) Sell
Bollinger Bands (100): (117.15 - 129.11) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.49 Buy
Relative Strength Index (14 RSI): 76.66 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (128.07 - 129.15) Buy
Bollinger Bands (100): (85.79 - 122.45) Buy

DORM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 122.16 Sell
20-day SMA: 123.72 Sell
50-day SMA: 125.74 Sell
200-day SMA: 125.61 Sell
8-day EMA: 122.25 Sell
20-day EMA: 123.38 Sell
50-day EMA: 123.87 Sell
200-day EMA: 120.93 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 129.38 Buy
20-day SMA: 128.73 Buy
50-day SMA: 119.37 Buy
200-day SMA: 99.85 Buy
8-day EMA: 129.26 Buy
20-day EMA: 127.9 Buy
50-day EMA: 120.09 Buy
200-day EMA: 103.72 Buy

Dorman Products Earnings Growth & DORM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.02 per share, an increase this year of $0.91 per share, and an increase next year of $0.67 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.

Dorman Products Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):